Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05274451
Title A Study to Investigate LYL797 in Adults with Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Lyell Immunopharma, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Scottsdale Arizona 85259 United States Details
University of California, Los Angeles Santa Monica California 90404 United States Details
Yale New Haven Hospital New Haven Connecticut 06510 United States Details
Georgetown University Washington District of Columbia 20007 United States Details
Mayo Clinic Jacksonville Florida 32224 United States Details
University of Miami Miami Florida 33136 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Mayo Clinic Rochester Minnesota 55902 United States Details
Montefiore Medical Center Bronx New York 10461 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of Oklahoma Oklahoma City Oklahoma 73104 United States Details
Oregon Health and Science University Hospital Portland Oregon 97239 United States Details
Sidney Kimmel Cancer Center, Jefferson University Hospital Philadelphia Pennsylvania 19107 United States Details
Sarah Cannon Research Institute and Tennessee Oncology Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98109 United States Details
Froedtert Hospital, Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field